EMA’s CTIS Framework: Decoding the EMA Clinical Trial Information System-A Practical Guide for Sponsors
- Sharan Murugan
- 1 day ago
- 2 min read
In an era of data-driven drug development, the European Medicines Agency (EMA) has launched a transformative regulatory framework: the Clinical Trial Information System (CTIS). This centralized digital platform, established under Regulation (EU) No 536/2014Â (the EU Clinical Trials Regulation or CTR), is designed to simplify and harmonize the clinical trial application and management process across the European Union (EU)Â and European Economic Area (EEA).

EMA updated and released the below documents to to help sponsors effectively use CTIS.
The Clinical Trial Information System (CTIS) is a web-based platform that serves as a single-entry portal for clinical trial submission, assessment, and supervision within the EU/EEA.
It supports:
Submission of initial clinical trial applications
Substantial and non-substantial modifications
Safety reporting and trial result publication
Real-time interaction between sponsors and national authorities
Public transparency of trial-related information
CTIS is built on a dual-access model:
Sponsor Workspace – for trial sponsors to submit and manage trials
Authority Workspace – for national regulatory and ethics bodies
Key EMA Resources and Insights
The Sponsor Handbook is a go-to manual that explains CTIS functionalities in detail, providing real-life use cases, workflows, and screenshots.
Explains how sponsors can create, submit, and manage clinical trials
Describes role-based user management and access control
Highlights communication protocols (e.g., RFIs – Requests for Information)
Breaks down the submission workflow for mono- and multi-member state trials
Emphasizes the importance of internal coordination to meet CTR deadlines
This catalogue outlines all available training modules and learning aids that support users of CTIS, categorized by role and system activity.
Lists more than 50+ resources: e-learnings, webinars, job aids, simulations
Covers essential operations like:
Creating an initial application
Responding to RFIs
Uploading trial results
Structured by user roles: Sponsor Admin, Clinical Trial Submitter, Viewer, etc.
Provides a navigation matrix to match training materials to user needs
This structured Excel-based template is designed for:
Initial trial applications
Adding additional Member States
Making substantial or non-substantial modifications to a trial
Captures critical trial data such as:
Study phase
Therapeutic area
Inclusion/exclusion criteria
Trial population and endpoints
Ensures data consistency and alignment with CTR Article 25Â requirements
This template facilitates ongoing trial communications such as:
Start and end of trial notifications
Temporary halts or resumptions
Submission of Annual Safety Reports (ASRs)
Uploading clinical trial results for public access
Data is organized in logical sections to guide:
Timely reporting of safety signals
Regulatory updates across trial Member States
Result disclosures post-trial completion
Includes flags for public disclosure vs confidential data
Sponsors now have the tools to navigate complex regulatory requirements with improved clarity, collaboration, and accountability. For pharmaceutical sponsors, embracing CTIS is no longer optional—it's essential for compliant, high-quality clinical trial operations in the EU.